Showing results (841-850 of 999) with videos related to
Sort By:
Pageof 100
JACC. Advances|February 21, 2025
Does Adiponectin Inform Cardiovascular Risk in Older Adults?: The ARIC StudyLayla A Abushamat, Xiaoming Jia, Lu Xu, et al.Circulation. Cardiovascular Genetics|December 19, 2012
Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studiesBing Yu, Maja Barbalic, Ariel Brautbar, et al.Circulation. Heart Failure|May 17, 2012
Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) StudySunil K Agarwal, Lloyd E Chambless, Christie M Ballantyne, et al.JACC. Heart Failure|May 19, 2023
Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans AffairsAliza Hussain, David Ramsey, Michelle Lee, et al.The Lancet. Diabetes & Endocrinology|December 21, 2025
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trialFrederick J Raal, Jean Bergeron, Daniel Gaudet, et al.Nature Metabolism|July 23, 2025
N-acetylaspartate from fat cells regulates postprandial body temperatureJessica B Felix, Pradip K Saha, Evelyn L de Groot, et al.American Heart Journal|December 5, 2009
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndromeGregory G Schwartz, Anders G Olsson, Christie M Ballantyne, et al.Diabetes Care|January 8, 2016
Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) StudyMauro Gori, Deepak K Gupta, Brian Claggett, et al.JAMA Cardiology|September 1, 2021
Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical TrialJarett D Berry, Vijay Nambi, Walter T Ambrosius, et al.JACC. Heart Failure|June 27, 2025
Linking Chronic Kidney Disease to Incident Heart Failure and Adverse Cardiac Remodeling Through the Plasma Proteome: The ARIC StudyLeo F Buckley, Pranav Dorbala, Victoria Lamberson, et al.Pageof 100